Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-99
Closed -$5 470
2020
Q4
$5 Buy
+99
New +$4.55K ﹤0.01% 609
2020
Q3
Sell
-650
Closed -$33 551
2020
Q2
$33 Sell
650
-80
-11% -$4.1K ﹤0.01% 435
2020
Q1
$35 Hold
730
0.01% 330
2019
Q4
$35K Buy
+730
New +$40.6K 0.01% 413

Other funds holding GSK

tru Independence's GSK Position: Q1 2021 in Review

tru Independence sold out of GSK (GSK) in Q1 2021, closing a stake of 99 shares — an estimated $5 sold.

tru Independence first reported a position in GSK in Q4 2019 and held it in 4 quarters. The position peaked at $35K in Q4 2019. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

  • tru Independence reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
  • tru Independence sold 99 GSK shares in Q1 2021, an estimated $5.
  • tru Independence first reported a position in GSK in Q4 2019 and held it in 4 quarters.
  • tru Independence's GSK position peaked at $35K in Q4 2019.
  • 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on tru Independence's 13F filing for Q1 2021, filed 20 May 2021.